Citadel Advisors
AORT icon

Citadel Advisors’s Artivion AORT Stock Holding History

Citadel Advisors’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,500
Closed -$61.5K – 12413
2025
Q1 		$61.5K Buy
2,500
+200
+9% +$5.55K ﹤0.01% 12087
2024
Q4 		$65.8K Buy
2,300
+1,400
+156% +$38.8K ﹤0.01% 12060
2024
Q3 		$24K Sell
900
-5,900
-87% -$153K ﹤0.01% 12637
2024
Q2 		$174K Buy
6,800
+5,300
+353% +$119K ﹤0.01% 10128
2024
Q1 		$31.7K Sell
1,500
-4,400
-75% -$81.9K ﹤0.01% 12645
2023
Q4 		$105K Buy
5,900
+5,700
+2,850% +$88.6K ﹤0.01% 10866
2023
Q3 		$3.03K Sell
200
-300
-60% -$4.86K ﹤0.01% 13640
2023
Q2 		$8.6K Sell
500
-1,000
-67% -$14.7K ﹤0.01% 13310
2023
Q1 		$19.6K Buy
1,500
+1,000
+200% +$12.8K ﹤0.01% 13079
2022
Q4 		$6.06K Buy
+500
New +$6K ﹤0.01% 13947
2015
Q4 		– Sell
-1,800
Closed -$18K – 8696
2015
Q3 		$18K Buy
1,800
+500
+38% +$5.22K ﹤0.01% 8223
2015
Q2 		$15K Sell
1,300
-1,500
-54% -$15.9K ﹤0.01% 8282
2015
Q1 		$29K Buy
+2,800
New +$30.8K ﹤0.01% 7706

Other funds holding AORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Citadel Advisors's AORT Position: Q1 2026 in Review

Citadel Advisors increased its Artivion (AORT) stake by 164% in Q1 2026, buying an estimated $1.74M and bringing the position to 70,869 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #5542.

Citadel Advisors first reported a position in AORT in Q3 2013 and has held it in 39 quarters since. The position peaked at $4.76M in Q2 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Citadel Advisors held 70,869 shares of Artivion worth $2.6M as of Q1 2026.
  • Citadel Advisors bought 43,990 Artivion shares in Q1 2026, an estimated $1.74M.
  • Artivion made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5542 holding.
  • Citadel Advisors first reported a position in Artivion in Q3 2013 and has held it in 39 quarters since.
  • Citadel Advisors's Artivion position peaked at $4.76M in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.